Microvascular Dysfunction in Obesity

Recruiting N/A Interventional Study
Obesity Endothelial Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
25 (estimated)
Sponsor
Florida State University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Impaired endothelial function is observed in disease states related to obesity, such as atherosclerosis, coronary artery disease, and diabetes. Reactive oxygen species (ROS) production and resultant oxidative stress contribute to the development of these obesity-related diseases. The enzyme NADPH-oxidase is a major source of oxidative stress within the vasculature, and has been linked with the Met…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * There will be no restrictions with regard to race, sex, or socioeconomic status. * Women will be premenopausal * Women will be on combined estrogen/progestin hormonal contraceptive therapy (oral pill, transdermal patch or vaginal ring). * Sedentary obese individuals will have …
Contacts

Robert C Hickner, PhD

850-644-1375

rhickner@fsu.edu

CONTACT